Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859559 · ClinicalTrials.gov registry record · NA
Evaluate Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Peripheral Intravenous Access
A NA study of Patients With Peripheral Intravenous Access Lines, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 1,189
- Enrollment target
- 1
- Study location
NCT01859559: Completed NA study of Patients With Peripheral Intravenous Access Lines, sponsored by George Washington University.
NCT01859559 is a NA study of Patients With Peripheral Intravenous Access Lines that has completed, run by George Washington University. The registered enrollment target is 1,189 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01859559, a NA study of Patients With Peripheral Intravenous Access Lines, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,189 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this randomized controlled trial (RCT) is to compare the success rate of obtaining peripheral vascular access with ultrasound guidance versus the traditional, landmark approach among patients with varying degrees of intravenous access difficulty. In addition to comparing overall initial success rates of the two methods, we will also compare the success rates by degree of intravenous access difficulty (3 main subject subgroups) and by operator experience (approximately 20 emergency department technicians). The main hypothesis is that the initial success rate will be significantly higher (5% or greater) for ultrasound guided peripheral intravenous access compared to landmark approach among patients who are judged to have difficult intravenous access but no significant difference (i.e. \< 5%) among patients judged to have easy intravenous access.
Primary Outcome
A successful cannulation (blood return or ability to infuse intravenous fluid without infiltration) on initial percutaneous needle puncture.
Conditions Studied
Interventions
- PROCEDURE Ultrasound-guided peripheral intravenous access line placement
- PROCEDURE Landmark Approach to peripheral intravenous access line placement
Study Locations (1)
District of Columbia
- George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,189 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01859559 record still lists
NCT01859559 is an interventional study that assigns participants to a tested intervention. Its 1,189 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Patients With Peripheral Intravenous Access Lines appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound-guided peripheral intravenous access line placement is the first listed.
NCT01859559 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01859559 about?
NCT01859559 is a clinical study titled "Evaluate Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Peripheral Intravenous Access". The primary objective of this randomized controlled trial (RCT) is to compare the success rate of obtaining peripheral vascular access with ultrasound guidance versus the traditional, landmark approach among patients with varying degrees of intravenous access difficulty. In addition to comparing ove...
What is the current status of trial NCT01859559?
This trial is currently completed. It is a NA study. The enrollment target is 1,189 participants. The study started on 2013-08. Estimated completion is 2014-09.
What conditions does trial NCT01859559 study?
This clinical trial studies the following conditions: Patients With Peripheral Intravenous Access Lines.
What interventions are being tested in trial NCT01859559?
The interventions under investigation include: Ultrasound-guided peripheral intravenous access line placement (PROCEDURE), Landmark Approach to peripheral intravenous access line placement (PROCEDURE).
Who is sponsoring clinical trial NCT01859559?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01859559 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01859559's enrollment target sits among peer trials
1,189 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia